Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-019827
Filing Date
2023-02-13
Accepted
2023-02-13 17:02:55
Documents
1
Group Members
FORESITE CAPITAL MANAGEMENT IV, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm236260d3_sc13ga.htm SC 13G/A 77276
  Complete submission text file 0001104659-23-019827.txt   78846
Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund IV, L.P. (Filed by) CIK: 0001704131 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Subject) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93402 | Film No.: 23619644
SIC: 2834 Pharmaceutical Preparations